The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“Indeed, most studies have shown that TAM exert several pro-tumor functions [ 19 , 100, 101].”
BackgroundSelf-citationInflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationBettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“The early differentiation of Treg and Th17 cells from naïve CD4 T cells shares a requirement for TGF-β, indicating substantial plasticity in the development of these lymphocyte subsets [160, 161].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 2×
“Along a current concept, M2-polarized myeloid cells promote tissue remodelling and angiogenesis and secrete several growth factors [99, 108].”
BackgroundSelf-citationMonocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“IL-23 is a crucial cytokine for the polarization of Th17 lymphocytes, in concert with IL-1β, IL-6 and TGF-β [148–153].”
BackgroundMassagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
The regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 2×
“[93] analysed TILs focusing on early metastatic invasion.”
BackgroundTerzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974 · cited 1×
“To the same end, activation of NF-κB and Akt pathways by pro-inflammatory signalling can promote β-catenin activation and favours colorectal cancer progression (extrinsic pathway) [36].”
BackgroundGender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Self-citationLinking Colorectal Cancer to Wnt Signaling
Bienz, M., & Clevers, H. (2000) · Cell · doi:10.1016/s0092-8674(00)00122-7 · Cited by 1,515
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
Self-citationAtreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905680 · Cited by 1,262
Macrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259 · cited 1×
“IL-6 modulates the expression of chemokines and adhesion molecules thus suppressing neutrophil infiltration, promoting the accumulation of mononuclear leukocytes and leading to the resolution of acute inflammation and the activation of acquired immunity [72, 73].”
BackgroundGuerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Cancer risk in patients with inflammatory bowel disease: A population-based study
Bernstein, C. N., Blanchard, J. F., Kliewer, E., & Wajda, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z · Cited by 1,165
Weitz, J., Koch, M., Debus, J., Höhler, T., Galle, P. R., & Büchler, M. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17706-x · Cited by 1,098
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,089
Self-citationInnate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, I. I., Littman, D. R., Maloy, K. J., & Powrie, F. (2010) · Nature · doi:10.1038/nature08949 · Cited by 1,067
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044
Self-citationINTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018 · cited 1×
“More recently, Langowski and colleagues [155] instead demonstrated that IL-23 expression is strongly increased in different types of cancer, including colon adenocarcinoma; IL-23 promoted tumor incidence and growth by stimulating inflammatory responses, up-regulation of MMP9, increased angiogenesis and reduced CD8 T-c…”
BackgroundSalama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
Celecoxib for the Prevention of Colorectal Adenomatous Polyps
Arber, N., Eagle, C. J., Spicak, J., Rácz, I., Dite, P., Hajer, J., Zavoral, M., Lechuga, M. J., Gerletti, P., Tang, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061652 · Cited by 975
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946 · cited 3×
“[81] used gp130 mice, which express a mutant gp130 receptor molecule with enhanced STAT3 activity, to demonstrate a role for increased STAT3 activation in the acceleration of colorectal cancer.”
BackgroundThe interface between innate and adaptive immunity
Hoebe, K., Janssen, E., & Beutler, B. (2004) · Nature Immunology · doi:10.1038/ni1004-971 · Cited by 916
Role of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
Self-citationChemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870 · cited 1×
“HIF1α interacts with the transcription factor NF-κB, resulting in the production of TNFα and of the chemokine receptor CXCR4 in renal-cell carcinoma cells, as well as in other malignancies [31, 32].”
BackgroundRas-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.977 · Cited by 847
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841
Self-citationThe Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S.-H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., & Schreiber, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 835
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., & Mukaida, N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32453 · Cited by 832
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Gupta, R. B., Harpaz, N., Itzkowitz, S., Hossain, S., Matula, S., Kornbluth, A., Bodian, C., & Ullman, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.001 · Cited by 786
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781
Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., & Moreno, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · Cited by 716
The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Sumimoto, H., Imabayashi, F., Iwata, T., & Kawakami, Y. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051848 · Cited by 698
Goerdt, S., & Orfanos, C. E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80014-x · Cited by 682
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665
SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling
Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J. E., Stark, G. R., & Li, X. (2003) · Nature Immunology · doi:10.1038/ni968 · Cited by 606
Colorectal cancer and genetic alterations in the Wnt pathway
Segditsas, S., & Tomlinson, I. (2006) · Oncogene · doi:10.1038/sj.onc.1210059 · Cited by 591 · cited 1×
“progression has been extensively demonstrated [136, 137].”
Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88
Rakoff-Nahoum, S., & Medzhitov, R. (2007) · Science · doi:10.1126/science.1140488 · Cited by 584
High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Forssell, J., Öberg, A., Henriksson, M. L., Stenling, R., Jung, A., & Palmqvist, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2073 · Cited by 566
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35073 · Cited by 548
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Bromberg, J., & Wang, T. C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.009 · Cited by 542
Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance
Huang, B., Zhao, J., Li, H., He, K.-L., Chen, Y., Mayer, L., Unkeless, J. C., & Xiong, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0784 · Cited by 542
The genetics of hereditary colon cancer
Rustgi, A. K. (2007) · Genes & Development · doi:10.1101/gad.1593107 · Cited by 529
Regulatory Lymphocytes and Intestinal Inflammation
Izcue, A., Coombes, J. L., & Powrie, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132657 · Cited by 507
Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition
Thuault, S., Valcourt, U., Petersen, M., Manfioletti, G., Heldin, C.-H., & Moustakas, A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512110 · Cited by 499
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Mantovani, A., Bonecchi, R., & Locati, M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1964 · Cited by 481 · cited 1×
“Since their discovery, the chemokine system has been strongly connected with cancer biology: tumor infiltration by macrophages has served as a paradigm of the chemokine-mediated recruitment of leukocytes at tissue peripheral [37–41].”
BackgroundSelf-citationDolcetti, R., Viel, A., Doglioni, C., Russo, A., Guidoboni, M., Capozzi, E., Vecchiato, N., Macrì, E., Fornasarig, M., & Boiocchi, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65436-3 · Cited by 480
BIERIE, B., & MOSES, H. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.006 · Cited by 477
Biswas, S. K., Sica, A., & Lewis, C. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2011 · Cited by 435
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
Itzkowitz, S. H., & Harpaz, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.025 · Cited by 423
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Kryczek, I., Wei, S., Szeliga, W., Vatan, L., & Zou, W. (2009) · Blood · doi:10.1182/blood-2008-09-177360 · Cited by 403
(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)07003-x · Cited by 386
Kim, J., Takeuchi, H., Lam, S. T., Turner, R. R., Wang, H.-J., Kuo, C., Foshag, L., Bilchik, A. J., & Hoon, D. S. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.078 · Cited by 378
Immune cells as mediators of solid tumor metastasis
DeNardo, D. G., Johansson, M., & Coussens, L. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9100-0 · Cited by 372
Regulation of the Macrophage Content of Neoplasms by Chemoattractants
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., & Mantovani, A. (1983) · Science · doi:10.1126/science.6828888 · Cited by 352
Self-citationMantovani, A., Sica, A., Allavena, P., Garlanda, C., & Locati, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.02.008 · Cited by 350
Self-citationInduction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
Borrello, M. G., Alberti, L., Fischer, A., Degl'Innocenti, D., Ferrario, C., Gariboldi, M., Marchesi, F., Allavena, P., Greco, A., Collini, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503039102 · Cited by 331
Self-citationNegus, R. P., Stamp, G. W., Relf, M. G., Burke, F., Malik, S. T., Bernasconi, S., Allavena, P., Sozzani, S., Mantovani, A., & Balkwill, F. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117933 · Cited by 315
Self-citationInflammatory cell infiltration of tumors: Jekyll or Hyde
Talmadge, J. E., Donkor, M., & Scholar, E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9072-0 · Cited by 313
Colonna, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.008 · Cited by 307
Microsatellite instability in colorectal cancer
Söreide, K., Janssen, E. A. M., Söiland, H., Körner, H., & Baak, J. P. A. (2006) · British Journal of Surgery · doi:10.1002/bjs.5328 · Cited by 302
Serum interleukin-6 levels in colorectal cancer patients—a summary of published results
Knüpfer, H., & Preiss, R. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0818-8 · Cited by 291
McLoughlin, R. M., Witowski, J., Robson, R. L., Wilkinson, T. S., Hurst, S. M., Williams, A. S., Williams, J. D., Rose-John, S., Jones, S. A., & Topley, N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17129 · Cited by 281 · cited 1×
“IL-6 modulates the expression of chemokines and adhesion molecules thus suppressing neutrophil infiltration, promoting the accumulation of mononuclear leukocytes and leading to the resolution of acute inflammation and the activation of acquired immunity [72, 73].”
BackgroundAntitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Germano, G., Frapolli, R., Simone, M., Tavecchio, M., Erba, E., Pesce, S., Pasqualini, F., Grosso, F., Sanfilippo, R., Casali, P. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2335 · Cited by 267
Self-citationIdentification of CD8 + CD25 + Foxp3 + suppressive T cells in colorectal cancer tissue
Chaput, N., Louafi, S., Bardier, A., Charlotte, F., Vaillant, J.-C., Ménégaux, F., Rosenzwajg, M., Lemoine, F., Klatzmann, D., & Taieb, J. (2009) · Gut · doi:10.1136/gut.2008.158824 · Cited by 264
Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer
Schimanski, C. C., Schwald, S., Simiantonaki, N., Jayasinghe, C., Gönner, U., Wilsberg, V., Junginger, T., Berger, M. R., Galle, P. R., & Moehler, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1195 · Cited by 257
Intestinal inflammation in mice deficient in Tir8 , an inhibitory member of the IL-1 receptor family
Garlanda, C., Riva, F., Polentarutti, N., Buracchi, C., Sironi, M., De Bortoli, M., Muzio, M., Bergottini, R., Scanziani, E., Vecchi, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308680101 · Cited by 254
Self-citationMast cells are an essential hematopoietic component for polyp development
Gounaris, E., Erdman, S. E., Restaino, C., Gurish, M. F., Friend, D. S., Gounari, F., Lee, D. M., Zhang, G., Glickman, J. N., Shin, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704620104 · Cited by 251
Laghi, L., Bianchi, P., Miranda, E., Balladore, E., Pacetti, V., Grizzi, F., Allavena, P., Torri, V., Repici, A., Santoro, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70186-x · Cited by 251
Self-citationReduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer
Malesci, A., Laghi, L., Bianchi, P., Delconte, G., Randolph, A., Torri, V., Carnaghi, C., Doci, R., Rosati, R., Montorsi, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0366 · Cited by 245
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
Kawada, K., Hosogi, H., Sonoshita, M., Sakashita, H., Manabe, T., Shimahara, Y., Sakai, Y., Takabayashi, A., Oshima, M., & Taketo, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210267 · Cited by 243
Savage, N. D. L., de Boer, T., Walburg, K. V., Joosten, S. A., van Meijgaarden, K., Geluk, A., & Ottenhoff, T. H. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2220 · Cited by 236
Barberá‐Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C., & Sampsel, J. W. (2002) · PubMed · Cited by 233
The Genetics of Colorectal Cancer
Calvert, P. M., & Frucht, H. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00012 · Cited by 233
PRALL, F. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.01.022 · Cited by 226 · cited 1×
“ated with a more favourable prognosis, less lymph node involvement and reduced occurrence of metastasis [8–12].”
BackgroundCanna, K., McArdle, P. A., McMillan, D. C., McNicol, A.-M., Smith, G. W., McKee, R. F., & McArdle, C. S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602419 · Cited by 226
Zhou, Q., Peng, R.-Q., Wu, X.-J., Xia, Q., Hou, J.-H., Ding, Y., Zhou, Q.-M., Zhang, X., Pang, Z.-Z., Wan, D.-S., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-13 · Cited by 219
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
Rollins, B. J., & Sunday, M. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3125 · Cited by 217
Das, J., Ren, G., Zhang, L., Roberts, A. I., Zhao, X., Bothwell, A. L. M., Van Kaer, L., Shi, Y., & Das, G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082286 · Cited by 216
CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in ApcMin/+ Mice
Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., & Schauer, D. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3104 · Cited by 211 · cited 1×
“As a confirmation of their potential protective effect, adoptive transfer of Treg into APC mice resulted in prevention of intestinal adenoma, as well as regression of some established tumors [166].”
BackgroundPrognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer
Funada, Y., Noguchi, T., Kikuchi, R., Takeno, S., Uchida, Y., & Gabbert, H. (2003) · Oncology Reports · doi:10.3892/or.10.2.309 · Cited by 205
Dinapoli, M. R., Calderon, C. L., & Lopez, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1323 · Cited by 204
Mantovani, A. (1994) · PubMed · Cited by 204
Self-citationChiba, T., Ohtani, H., Mizoi, T., Naito, Y., Sato, E., Nagura, H., Ohuchi, A., Ohuchi, K., Shiiba, K., Kurokawa, Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602201 · Cited by 201
TGF‐β indirectly favors the development of human Th17 cells by inhibiting Th1 cells
Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Querci, V., Palma, R. D., Liotta, F., Cosmi, L., Maggi, E., Romagnani, S., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838748 · Cited by 200
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Brown-Swigart, L., & Evan, G. I. (2006) · Genes & Development · doi:10.1101/gad.1455706 · Cited by 200
Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice
Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., & Mukaida, N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1451 · Cited by 200
CXCL10 Promotes Invasion-Related Properties in Human Colorectal Carcinoma Cells
Zipin-Roitman, A., Meshel, T., Sagi-Assif, O., Shalmon, B., Avivi, C., Pfeffer, R. M., Witz, I. P., & Ben-Baruch, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3087 · Cited by 194
Bailey, C., Negus, R., Morris, A., Ziprin, P., Goldin, R., Allavena, P., Peck, D., & Darzi, A. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9060-3 · Cited by 192
Self-citationThomassen, E., Renshaw, B. R., & Sims, J. E. (1999) · Cytokine · doi:10.1006/cyto.1998.0452 · Cited by 183
Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7
Günther, K., Leier, J., Henning, G., Dimmler, A. W., Weißbach, R., Hohenberger, W., & Förster, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21123 · Cited by 182
Role of Toll-like receptors in gastrointestinal malignancies
Fukata, M., & Abreu, M. T. (2008) · Oncogene · doi:10.1038/sj.onc.1210908 · Cited by 178
Prognostic influence of tumor‐associated eosinophilic infiltrate in colorectal carcinoma
Fernández‐Aceñero, M. J., Galindo‐Gallego, M., Sanz, J., & Aljama, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1544::aid-cncr7>3.3.co;2-j · Cited by 175
Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells
Schneider, M. R., Hoeflich, A., Fischer, J. R., Wolf, E., Sordat, B., & Lahm, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00401-2 · Cited by 172
Ohno, S., Inagawa, H., Dhar, D. K., Fujii, T., Ueda, S., Tachibana, M., Suzuki, N., Inoue, M., Soma, G., & Nagasue, N. (2003) · PubMed · Cited by 171
Khorana, A. A., Ryan, C., Cox, C., Eberly, S. W., & Sahasrabudhe, D. M. (2003) · Cancer · doi:10.1002/cncr.11152 · Cited by 170
Vetrano, S., Borroni, E. M., Sarukhan, A., Savino, B., Bonecchi, R., Correale, C., Arena, V., Fantini, M. C., Roncalli, M. G., Malesci, A., et al. (2009) · Gut · doi:10.1136/gut.2009.183772 · Cited by 162
Self-citationThe Tumor Microenvironment: The Making of a Paradigm
Witz, I. P. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0025-8 · Cited by 161
Xu, L., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Chung, D. C., Lauwers, G. Y., Samuel, R., Shellito, P., Czito, B. G., Lin, P.-C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2099 · Cited by 161
Banerjea, A., Ahmed, S., Hands, R. E., Huang, F., Han, X., Shaw, P. M., Feakins, R. M., Bustin, S. A., & Dorudi, S. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-21 · Cited by 154
The role of chemokines in intestinal inflammation and cancer
Wang, D., DuBois, R. N., & Richmond, A. J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.003 · Cited by 152
Yaal‐Hahoshen, N., Shina, S., Leider–Trejo, L., Barnea, I., Shabtai, E. L., Azenshtein, E., Greenberg, I., Keydar, I., & Ben‐Baruch, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0074 · Cited by 151
The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β
Kaler, P., Godasi, B. N., Augenlicht, L. H., & Klampfer, L. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0030-y · Cited by 148
Nunes, M., Shi, C., & Greenberger, L. M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.21.3.1 · Cited by 148
Mundy, G. R. (2008) · Bone · doi:10.1016/j.bone.2007.12.198 · Cited by 147
TGFβ1, a ‘Jack of all trades’: the link with pro-inflammatory IL-17-producing T cells
Veldhoen, M., & Stockinger, B. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.001 · Cited by 147
Nagtegaal, I. D., Marijnen, C. A. M., Kranenbarg, E. M., Mulder-Stapel, A. A., Hermans, J., van de Velde, C. J., & van Krieken, J. H. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-7 · Cited by 139
Differential Regulation of Chemokines by IL-17 in Colonic Epithelial Cells
Lee, J. W., Wang, P., Kattah, M. G., Youssef, S., Steinman, L., DeFea, K., & Straus, D. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6536 · Cited by 137
Mismatch Repair and the Hereditary Non-polyposis Colorectal Cancer Syndrome (HNPCC)
Müller, A., & Fishel, R. A. (2002) · Cancer Investigation · doi:10.1081/cnv-120000371 · Cited by 131
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Loddenkemper, C., Schernus, M., Noutsias, M., Stein, H., Thiel, E., & Nagorsen, D. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-52 · Cited by 129
Garlanda, C., Riva, F., Veliz, T., Polentarutti, N., Pasqualini, F., Radaelli, E., Sironi, M., Nebuloni, M., Zorini, E. O., Scanziani, E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0560 · Cited by 126
Self-citationBussell, K. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1674 · Cited by 121
Tumour‐associated leucocytes: Friends or foes in breast carcinoma
O'Sullivan, C., & Lewis, C. E. (1994) · The Journal of Pathology · doi:10.1002/path.1711720302 · Cited by 119
Herbeuval, J., Lelièvre, E., Lambert, C., Dy, M., & Genin, C. (2004) · Journal of Immunology · doi:10.4049/jimmunol.172.7.4630 · Cited by 118
Gounaris, E. G., Tung, C., Restaino, C. R., Maehr, R., Köhler, R. H., Joyce, J. A., Plough, H. L., Barrett, T. A., Weissleder, R., & Khazaie, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002916 · Cited by 117
Polentarutti, N., Rol, G. P., Muzio, M., Bosisio, D., Camnasio, M., Riva, F., Zoja, C., Benigni, A., Tomasoni, S., Vecchi, A., et al. (2003) · PubMed · Cited by 116
Self-citationActivated macrophages induce metastatic behavior of colon cancer cells
Jedinak, A., Dudhgaonkar, S. P., & Slíva, D. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.03.004 · Cited by 114
Natural killer cells infiltrating colorectal cancer and MHC class I expression
Sandel, M. H., Speetjens, F. M., Menon, A. G., Albertsson, P., Basse, P. H., Hokland, M., Nagelkerke, J. F., Tollenaar, R. A. E. M., van de Velde, C. J. �., & Kuppen, P. J. K. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.039 · Cited by 112
MMP-9 Is Differentially Expressed in Primary Human Colorectal Adenocarcinomas and Their Metastases
Illemann, M., Bird, N. C., Majeed, A. W., Sehested, M., Lærum, O. D., Lund, L. R., Danø, K., & Nielsen, B. S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0003 · Cited by 104
Chapter 5 Expression of Chemokines and Chemokine Receptors in Human Colon Cancer
Erreni, M., Bianchi, P. P., Laghi, L., Mirolo, M., Fabbri, M., Locati, M., Mantovani, A., & Allavena, P. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05205-7 · Cited by 101
Self-citationChemotactic factors, passive invasion and metastasis of cancer cells
Opdenakker, G., & Damme, J. V. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90079-m · Cited by 92
The role of inflammation in the pathogenesis of colorectal cancer
McConnell, B. B., & Yang, V. W. (2009) · Current Colorectal Cancer Reports · doi:10.1007/s11888-009-0011-z · Cited by 83
CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway
Sturm, A. (2004) · Cytokine · doi:10.1016/j.cyto.2004.09.007 · Cited by 77
Mantovani, A., Locati, M., Polentarutti, N., Vecchi, A., & Garlanda, C. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003473 · Cited by 71
Self-citationPancione, M., Forte, N. R., Sabatino, L., Tomaselli, E., Parente, D., Febbraro, A., & Colantuoni, V. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.08.019 · Cited by 68
Induction of systemic immunity by expression of interleukin‐23 in murine colon carcinoma cells
Wang, Y., Ugai, S., Shimozato, O., Yu, L., Kawamura, K., Yamamoto, H., Yamaguchi, T., Saisho, H., & Tagawa, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11160 · Cited by 65
Reinacher-Schick, A., Baldus, S. E., Romdhana, B., Landsberg, S., Zapatka, M., Mönig, S., Hölscher, A. H., Dienes, H. P., Schmiegel, W., & Schwarte‐Waldhoff, I. (2004) · The Journal of Pathology · doi:10.1002/path.1516 · Cited by 63
Brozek, W., Bises, G., Girsch, T., Cross, H., Kaiser, H., & Peterlik, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.014 · Cited by 62
Prall, F., Dührkop, T., Weirich, V., Ostwald, C., Nizze, H., & Barten, M. (2004) · Pathology - Research and Practice · doi:10.1016/s0344-0338(04)80716-7 · Cited by 44
Pereira, C., Medeiros, R., & Dinis-Ribeiro, M. J. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32830ce7ba · Cited by 43
Sugita, J., Ohtani, H., Mizoi, T., Saito, K., Shiiba, K., Sasaki, I., Matsuno, S., Yagita∥, H., Miyazawa, M., & Nagura, H. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02175.x · Cited by 43
Genetic Alterations in Locally Advanced Stage II/III Colon Cancer: A Search for Prognostic Markers
Westra, J. L., Plukker, J. T. M., Buys, C. H. C. M., & Hofstra, R. M. W. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.n.024 · Cited by 39
Cross, J. T., Poole, E. M., & Ulrich, C. M. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500487 · Cited by 38
Popović, Z. V., Sandhoff, R., Sijmonsma, T., Kaden, S., Jennemann, R., Kiss, É., Tone, E., Autschbach, F., Platt, N., Malle, E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6770 · Cited by 37
Is colony‐stimulating factor‐1 a key mediator of breast cancer invasion and metastasis?
Balmain, A., Barrett, J. C., Moses, H. L., Scholl, S., Crocker, P. R., Tang, R., Pouillart, P., & Pollard, J. W. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070402 · Cited by 34
High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma
Stanilov, N., Miteva, L. D., Mintchev, N., & Stanilova, S. A. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0588-8 · Cited by 31
Konur, A., Kreutz, M. P., Knüchel, R., Krause, S. W., & Andreesen, R. (1998) · International Journal of Cancer · Cited by 29
Laghi, L., Bianchi, P. P., & Malesci, A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50199 · Cited by 10
Cited by
Tumor-associated macrophages: an accomplice in solid tumor progression
Chen, Y., Song, Y., Du, W., Gong, L., Chang, H., & Zou, Z. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0568-z · Cited by 1,096
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Cannarile, M. A., Weisser, M., Jacob, W., Jegg, A.-M., Ries, C. H., & Rüttinger, D. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0257-y · Cited by 1,020
Macrophages in Tumor Microenvironments and the Progression of Tumors
Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/948098 · Cited by 1,003
“The cytokine IL-23 is considered to promote tumor incidence and growth by upregulating MMP9, thereby stimulating inflammatory responses [62, 63].”
BackgroundTumor associated macrophages and neutrophils in cancer
Galdiero, M. R., Bonavita, E., Barajon, I., Garlanda, C., Mantovani, A., & Jaillon, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.003 · Cited by 597
Self-citationGenetic and biological hallmarks of colorectal cancer
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 573
Metadata
- Authors
- Erreni, M., Mantovani, A., & Allavena, P.
- Venue
- Cancer Microenvironment
- Published
- 2010-09-17
- Volume
- 4
- Issue
- 2
- Pages
- 141-154
- ISSN
- 1875-2284 (ISSN-L)
- 1875-2292
- OpenAlex
- W2034099804
- Cited by
- 325
- References
- 169
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.